Nanoparticle-based diagnostic solutions

Lybe Scientific is a newly established biotechnology company within diagnostics and is based on interdisciplinary research at NTNU. Lybe Scientific's first product is a diagnostic solution currently used for COVID-19 diagnostics with approximately 6.2 million units sold domestically and internationally during the pandemic. This solution has been prepared from two strong professional environments within molecular biology and chemical engineering. With a basis in the underlying technology, Lyb Scientific's opportunity is to continue to further develop this platform technology, and the vision is to be a leading supplier of cost-effective products for a wide range of life science and diagnostic purposes. This project seeks to cover Lybe Scientific's need for R&D activities around new functionalized nanoparticles for RNA and DNA applications in a selection of biological sample materials. The main goal is to expand the product portfolio of solutions for different clinical application areas and establish efficient production processes for these products.